List of Tables
Table 1. Global KRAS Inhibitor Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global KRAS Inhibitor Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global KRAS Inhibitor Market Competitive Situation by Manufacturers in 2025
Table 4. Global KRAS Inhibitor Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global KRAS Inhibitor Sales Market Share by Manufacturers (2021–2026)
Table 6. Global KRAS Inhibitor Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global KRAS Inhibitor Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market KRAS Inhibitor Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of KRAS Inhibitor, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of KRAS Inhibitor, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of KRAS Inhibitor, Product Types and Applications
Table 12. Global Key Manufacturers of KRAS Inhibitor, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global KRAS Inhibitor Companies by Tier (Tier 1, Tier 2, Tier 3), based on KRAS Inhibitor Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global KRAS Inhibitor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global KRAS Inhibitor Sales by Region (K Units), 2021–2026
Table 18. Global KRAS Inhibitor Sales Market Share by Region (2021–2026)
Table 19. Global KRAS Inhibitor Sales by Region (K Units), 2027–2032
Table 20. Global KRAS Inhibitor Sales Market Share by Region (2027–2032)
Table 21. Global KRAS Inhibitor Revenue by Region (US$ Million), 2021–2026
Table 22. Global KRAS Inhibitor Revenue Market Share by Region (2021–2026)
Table 23. Global KRAS Inhibitor Revenue by Region (US$ Million), 2027–2032
Table 24. Global KRAS Inhibitor Revenue Market Share by Region (2027–2032)
Table 25. North America KRAS Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America KRAS Inhibitor Sales by Country (K Units), 2021–2026
Table 27. North America KRAS Inhibitor Sales by Country (K Units), 2027–2032
Table 28. North America KRAS Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 29. North America KRAS Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 30. Europe KRAS Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe KRAS Inhibitor Sales by Country (K Units), 2021–2026
Table 32. Europe KRAS Inhibitor Sales by Country (K Units), 2027–2032
Table 33. Europe KRAS Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 34. Europe KRAS Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific KRAS Inhibitor Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific KRAS Inhibitor Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific KRAS Inhibitor Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific KRAS Inhibitor Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific KRAS Inhibitor Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America KRAS Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America KRAS Inhibitor Sales by Country (K Units), 2021–2026
Table 42. Latin America KRAS Inhibitor Sales by Country (K Units), 2027–2032
Table 43. Latin America KRAS Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America KRAS Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa KRAS Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa KRAS Inhibitor Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa KRAS Inhibitor Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa KRAS Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa KRAS Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 50. Global KRAS Inhibitor Sales (K Units) by Type (2021–2026)
Table 51. Global KRAS Inhibitor Sales (K Units) by Type (2027–2032)
Table 52. Global KRAS Inhibitor Sales Market Share by Type (2021–2026)
Table 53. Global KRAS Inhibitor Sales Market Share by Type (2027–2032)
Table 54. Global KRAS Inhibitor Revenue (US$ Million) by Type (2021–2026)
Table 55. Global KRAS Inhibitor Revenue (US$ Million) by Type (2027–2032)
Table 56. Global KRAS Inhibitor Revenue Market Share by Type (2021–2026)
Table 57. Global KRAS Inhibitor Revenue Market Share by Type (2027–2032)
Table 58. Global KRAS Inhibitor Price (US$/Unit) by Type (2021–2026)
Table 59. Global KRAS Inhibitor Price (US$/Unit) by Type (2027–2032)
Table 60. Global KRAS Inhibitor Sales (K Units) by Application (2021–2026)
Table 61. Global KRAS Inhibitor Sales (K Units) by Application (2027–2032)
Table 62. Global KRAS Inhibitor Sales Market Share by Application (2021–2026)
Table 63. Global KRAS Inhibitor Sales Market Share by Application (2027–2032)
Table 64. Global KRAS Inhibitor Revenue (US$ Million) by Application (2021–2026)
Table 65. Global KRAS Inhibitor Revenue (US$ Million) by Application (2027–2032)
Table 66. Global KRAS Inhibitor Revenue Market Share by Application (2021–2026)
Table 67. Global KRAS Inhibitor Revenue Market Share by Application (2027–2032)
Table 68. Global KRAS Inhibitor Price (US$/Unit) by Application (2021–2026)
Table 69. Global KRAS Inhibitor Price (US$/Unit) by Application (2027–2032)
Table 70. Amgen Company Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen KRAS Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Amgen KRAS Inhibitor Product
Table 74. Amgen Recent Developments/Updates
Table 75. Boehringer Ingelheim Company Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim KRAS Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Boehringer Ingelheim KRAS Inhibitor Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. BridgeBio Pharma Company Information
Table 81. BridgeBio Pharma Description and Business Overview
Table 82. BridgeBio Pharma KRAS Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. BridgeBio Pharma KRAS Inhibitor Product
Table 84. BridgeBio Pharma Recent Developments/Updates
Table 85. Erasca Company Information
Table 86. Erasca Description and Business Overview
Table 87. Erasca KRAS Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Erasca KRAS Inhibitor Product
Table 89. Erasca Recent Developments/Updates
Table 90. Innovent Biologics Company Information
Table 91. Innovent Biologics Description and Business Overview
Table 92. Innovent Biologics KRAS Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Innovent Biologics KRAS Inhibitor Product
Table 94. Innovent Biologics Recent Developments/Updates
Table 95. Incyte Company Information
Table 96. Incyte Description and Business Overview
Table 97. Incyte KRAS Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Incyte KRAS Inhibitor Product
Table 99. Incyte Recent Developments/Updates
Table 100. Mirati Therapeutics Company Information
Table 101. Mirati Therapeutics Description and Business Overview
Table 102. Mirati Therapeutics KRAS Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Mirati Therapeutics KRAS Inhibitor Product
Table 104. Mirati Therapeutics Recent Developments/Updates
Table 105. Novartis Company Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis KRAS Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Novartis KRAS Inhibitor Product
Table 109. Novartis Recent Developments/Updates
Table 110. Jemincare Company Information
Table 111. Jemincare Description and Business Overview
Table 112. Jemincare KRAS Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Jemincare KRAS Inhibitor Product
Table 114. Jemincare Recent Developments/Updates
Table 115. Cardiff Oncology Company Information
Table 116. Cardiff Oncology Description and Business Overview
Table 117. Cardiff Oncology KRAS Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Cardiff Oncology KRAS Inhibitor Product
Table 119. Cardiff Oncology Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. KRAS Inhibitor Distributors List
Table 123. KRAS Inhibitor Customers List
Table 124. KRAS Inhibitor Market Trends
Table 125. KRAS Inhibitor Market Drivers
Table 126. KRAS Inhibitor Market Challenges
Table 127. KRAS Inhibitor Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of KRAS Inhibitor
Figure 2. Global KRAS Inhibitor Market Value by Type (US$ Million), 2021–2032
Figure 3. Global KRAS Inhibitor Market Share by Type: 2025 & 2032
Figure 4. Lung Cancer Product Picture
Figure 5. Pancreatic Cancer Product Picture
Figure 6. Colorectal Cancer Product Picture
Figure 7. Others Product Picture
Figure 8. Global KRAS Inhibitor Market Value by Application (US$ Million), 2021–2032
Figure 9. Global KRAS Inhibitor Market Share by Application: 2025 & 2032
Figure 10. Clinic Laboratories
Figure 11. Cancer Diagnostic Centres
Figure 12. Hospitals
Figure 13. Others
Figure 14. Global KRAS Inhibitor Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global KRAS Inhibitor Market Size (US$ Million), 2021–2032
Figure 16. Global KRAS Inhibitor Sales (K Units), 2021–2032
Figure 17. Global KRAS Inhibitor Average Price (US$/Unit), 2021–2032
Figure 18. KRAS Inhibitor Report Years Considered
Figure 19. KRAS Inhibitor Sales Share by Manufacturers in 2025
Figure 20. Global KRAS Inhibitor Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global KRAS Inhibitor Players: Market Share by Revenue in KRAS Inhibitor in 2025
Figure 22. KRAS Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global KRAS Inhibitor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America KRAS Inhibitor Sales Market Share by Country (2021–2032)
Figure 25. North America KRAS Inhibitor Revenue Market Share by Country (2021–2032)
Figure 26. United States KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe KRAS Inhibitor Sales Market Share by Country (2021–2032)
Figure 29. Europe KRAS Inhibitor Revenue Market Share by Country (2021–2032)
Figure 30. Germany KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific KRAS Inhibitor Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific KRAS Inhibitor Revenue Market Share by Region (2021–2032)
Figure 37. China KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America KRAS Inhibitor Sales Market Share by Country (2021–2032)
Figure 45. Latin America KRAS Inhibitor Revenue Market Share by Country (2021–2032)
Figure 46. Mexico KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa KRAS Inhibitor Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa KRAS Inhibitor Revenue Market Share by Country (2021–2032)
Figure 52. Turkey KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE KRAS Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of KRAS Inhibitor by Type (2021–2032)
Figure 56. Global Revenue Market Share of KRAS Inhibitor by Type (2021–2032)
Figure 57. Global KRAS Inhibitor Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of KRAS Inhibitor by Application (2021–2032)
Figure 59. Global Revenue Market Share of KRAS Inhibitor by Application (2021–2032)
Figure 60. Global KRAS Inhibitor Price (US$/Unit) by Application (2021–2032)
Figure 61. KRAS Inhibitor Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
